USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
09 May 2023 | 02:45 PM GMT

How to Structure a Deal Between DTx and Pharma Companies?

Anchored by:

Rick Bartels
President/Founder
DTXCC

Participants:

Rick Bartels President/Founder DTxCC
Rick Bartels
President/Founder DTxCC
Arshia Gratiot Founder and CEOEupnoos
Arshia Gratiot
Founder and CEOEupnoos
Ed Melendez AdvisorPeer Collective
Ed Melendez
AdvisorPeer Collective
Hannes Klöpper FounderHelloBetter
Hannes Klöpper
FounderHelloBetter
Jonas Duss Principal / Founder1sourcehealth.com
Jonas Duss
Principal / Founder1sourcehealth.com
Mark Wuttke CEODopavision
Mark Wuttke
CEODopavision
Matt Norton VP of Marketing & Commercial DevelopmentS3 Connected Health
Matt Norton
VP of Marketing & Commercial DevelopmentS3 Connected Health
Mike Pace Founder & CEOPalmHealthCo
Mike Pace
Founder & CEOPalmHealthCo

About this Meeting

Structuring a deal between pharmaceutical companies and digital therapeutics (DTx) companies can be complex, and the specifics will depend on various factors, including the therapeutic area to which the deal pertains, market size, and development stage of the DTx solution. Despite the potential benefits of pharma-DTx partnerships, most collaborations thus far have remained at the pilot stage, with limited success. In this meeting, we will explore how DTx companies can best approach pharma to establish sustainable partnerships, and how pharma should be evaluating DTx. Register now to be part of this roundtable discussion where we will delve into:  

  • The most strategic DTx-pharma partnership models. When should a DTx company go after a licensing agreement, versus co-development or multi-year collaboration?  
  • Revenue generation in the short and long term. What needs to be done so these partnerships are optimally set up to realise their future revenue generation potential?  
  • Regional differences in forming partnerships. How to create pharma-DTx partnerships that can span multiple regions?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.